Skip to main content
. 2023 Dec 19;13:1320818. doi: 10.3389/fonc.2023.1320818

Table 2.

Acute toxicity in patients treated by RT-TACE-LEN or TACE-LEN.

Toxicity Any Grade p value Grade 3-4 p value
Group, No. (%) Group, No. (%)
RT-TACE-LEN
(n= 51)
TACE-LEN
(n= 51)
RT-TACE-LEN
(n= 51)
TACE-LEN
(n= 51)
Ascites 7 (13.7) 6 (11.8) 0.767 3 (5.9) 2 (3.9) 0.645
Elevated ALT 12 (23.5) 10 (19.6) 0.630 8 (15.7) 8 (15.7) >.999
Elevated AST 13 (25.5) 11 (21.6) 0.641 10 (19.6) 9 (17.6) 0.799
Hyperbilirubinemia 10 (19.6) 9 (17.6) 0.799 6 (11.8) 5 (9.8) 0.750
Hypoalbuminemia 9 (17.6) 7 (13.7) 0.586 1 (2.0) 1 (2.0) >0.999
Total 51 (100.0) 33 (64.7) < 0.001 28 (54.9) 25 (49.0) 0.552

ALT, alanine aminotransferase; AST, aspartate aminotransferase; RT, radiation; TACE, trans arterial chemoembolization; LEN, lenvatinib.